US FDA approves Moderna’s Covid-19 vaccine, Spikevax in children aged 6 months through 11 years at increased risk for Covid-19 disease: Cambridge, Massachusetts Saturday, July 1 ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

All Pro Overhead Garage Doors, a top garage door service with more than 20 years in the business, is putting more focus on ...

Amid the sultry summer months, a few signs of fall become apparent, such as the appearance of school supplies on stores ...

The new cases are part of a national surge fueled by multiple factors, including a large outbreak in West Texas, illnesses ...

Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...

The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval ...

The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one ...

The U.S. Food and Drug Administration approved "Spikevax," Moderna's vaccine for children aged 6 months to 11 years old. The ...

Pipeworks Plumbing and Construction is expanding into new markets. Traditionally recognized for its residential plumbing ...

TORONTO, ON / ACCESS Newswire / July 11, 2025 / Northern Superior Resources Inc. (“Northern Superior” or the “Company“) (TSXV ...

Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S.